Acute myeloid leukemia (AML) is, as other types of cancer, a genetic disorder of somatic cells. The detection of somatic molecular abnormalities that may cause and maintain AML is crucial for patient stratification. The development of mutation-specific therapeutic interventions will hopefully increase cure rates and improve patients' quality of life. This review illustrates how next generation sequencing technologies are changing the study of cancer genomics of adult AML patients.
Genomics of acute myeloid leukemia : the next generation / L. Riva, L. Luzi, P.G. Pelicci. - In: FRONTIERS IN ONCOLOGY. - ISSN 2234-943X. - 2:40(2012 May 01), pp. Article 40.40-1-Article 40.40-12. [10.3389/fonc.2012.00040]
Genomics of acute myeloid leukemia : the next generation
P.G. Pelicci
2012
Abstract
Acute myeloid leukemia (AML) is, as other types of cancer, a genetic disorder of somatic cells. The detection of somatic molecular abnormalities that may cause and maintain AML is crucial for patient stratification. The development of mutation-specific therapeutic interventions will hopefully increase cure rates and improve patients' quality of life. This review illustrates how next generation sequencing technologies are changing the study of cancer genomics of adult AML patients.
| File | Dimensione | Formato | |
|---|---|---|---|
|
fonc-02-00040.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
335.12 kB
Formato
Adobe PDF
|
335.12 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
